Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant 5-FU/Leucovorin/Levamisole vs Infusional 5-FU/Levamisole in Colon Cancer
NCT00002593Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Dec 1994
- Primary completion
- Dec 1999
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial in colon cancer comparing 5-FU/Leucovorin/Levamisole with Infusional 5-FU + Levamisole (2 arms). Primary endpoint: Overall Survival. Started Dec 1994; status: completed.
02
Drugs
fluorouracilfolinic acidlevamisole
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00002593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002593.